US 12180300
Targeting moiety-drug grafted immune cell compositions and methods of use
granted A61KA61K47/60A61K47/68033
Quick answer
US patent 12180300 (Targeting moiety-drug grafted immune cell compositions and methods of use) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K47/60, A61K47/68033, A61K47/6849, A61K47/6851